Concepedia

Publication | Open Access

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

DOIFull Paper Access

113

Citations

17

References

2014

Year

AnnCatherine M. Downing, Bruce J. Kinon, Brian A. Millen, Lu Zhang, Lin Liu, Ronald Brenner, Tami Jo Rayle, Laura Nisenbaum, Fangyi Zhao, Juan Carlos Gómez
BMC Psychiatry

Abstract

A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Comparator Study of 2 Doses of LY2140023 Versus Placebo in Patients With DSM-IV-TR SchizophreniaClinicalTrials.gov identifier: NCT01086748.

References

YearCitations

Page 1